» Articles » PMID: 30295752

Texture Analysis of Computed Tomography Data Using Morphologic and Metabolic Delineation of Esophageal Cancer-relation to Tumor Type and Neoadjuvant Therapy Response

Overview
Journal Dis Esophagus
Specialty Gastroenterology
Date 2018 Oct 9
PMID 30295752
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The prognostic values of image-based tumor texture analysis based on computed tomography (CT) and of limiting the segmented tumor volume to metabolically active regions using fludeoxyglucose-positron emission tomography (FDG-PET) were studied in 25 patients with esophageal adenocarcinoma and 11 patients with squamous cell carcinoma. The aims of this study are to describe their CT-image-based texture characteristics before and after neoadjuvant therapy and to evaluate whether limiting the examined tumor volume to metabolically active regions detected with FDG-PET image data would further improve their value. Textural parameters (homogeneity, energy, entropy, contrast, and correlation) based on gray-level co-occurrence matrices (GLCM) were calculated for 3D volumes of segmented esophageal tumors before and after neoadjuvant chemotherapy or radiochemotherapy. Histopathological data after surgical resection and textural parameters before and after neoadjuvant treatment were compared using the Mann-Whitney U test. Significant differences in the textural parameters were observed between adenocarcinoma and squamous cell carcinoma for homogeneity, energy, inertia, and correlation. The use of contrast media during scanning resulted in significant differences in homogeneity, energy, entropy, and inertia for adenocarcinoma but not squamous cell carcinoma. There was also a significant difference in all textural parameters between pathological T status for ypT0-ypT2 and ypT3-ypT4 adenocarcinomas, but not in squamous cell carcinoma patients. No additional value was found from using PET image data to aid segmentation of CT images.

Citing Articles

Radiomics model based on contrast-enhanced CT texture features for pretreatment prediction of overall survival in esophageal neuroendocrine carcinoma.

Zhou Y, Song L, Xia J, Liu H, Xing J, Gao J Front Oncol. 2023; 13:1225180.

PMID: 37664013 PMC: 10473874. DOI: 10.3389/fonc.2023.1225180.


Prognostic value of pre-therapeutic FDG-PET radiomic analysis in gastro-esophageal junction cancer.

Amrane K, Thuillier P, Bourhis D, Le Meur C, Quere C, Leclere J Sci Rep. 2023; 13(1):5789.

PMID: 37031233 PMC: 10082755. DOI: 10.1038/s41598-023-31587-8.


Volumetric Evaluation of Staging F-FDG PET/CT Images in Patients with Esophageal Cancer.

Karahan Sen N, Aksu A, Capa Kaya G Mol Imaging Radionucl Ther. 2022; 31(3):216-222.

PMID: 36268888 PMC: 9586008. DOI: 10.4274/mirt.galenos.2022.38980.


Change in Density Not Size of Esophageal Adenocarcinoma During Neoadjuvant Chemotherapy Is Associated with Improved Survival Outcomes.

Tankel J, Soderstrom H, Reizine E, Artho G, Calderone A, Mueller C J Gastrointest Surg. 2022; 26(12):2417-2425.

PMID: 36214951 DOI: 10.1007/s11605-022-05422-w.


Radiomic assessment of oesophageal adenocarcinoma: a critical review of 18F-FDG PET/CT, PET/MRI and CT.

OShea R, Rookyard C, Withey S, Cook G, Tsoka S, Goh V Insights Imaging. 2022; 13(1):104.

PMID: 35715706 PMC: 9206060. DOI: 10.1186/s13244-022-01245-0.